Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Protalix BioTherapeutics, Inc. (PLX)

Income Statement Business | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues:  
    License and R&D services       1.8  
    Goods       19.2  
Total revenues  47.638.462.954.734.221.122.84.4
            Revenue growth  24.2%-39.0%15.0%59.7%62.4%-7.6%422.8%23.9%
Cost of goods sold  19.616.310.910.99.315.2-8.40.7
Gross profit  28.022.052.043.824.95.831.23.6
            Gross margin  58.9%57.4%82.7%80.1%72.8%27.7%136.8%83.3%
Selling, general and administrative  11.712.711.19.910.911.59.47.3
Research and development  29.329.738.244.633.361.055.044.9
Other operating expenses       -32.2 -24.9
EBITDA   [+]-11.9-19.34.0-9.1-17.6-32.6-31.2-21.3
            EBITDA margin  -25.0%-50.4%6.4%-16.6%-51.5%-154.6%-136.7%-488.1%
Depreciation and amortization  1.11.11.31.61.71.92.02.4
EBIT   [+]-13.0-20.52.7-10.7-19.3-34.5-33.2-23.7
            EBIT margin  -27.3%-53.4%4.3%-19.6%-56.4%-163.8%-145.4%-542.4%
Other income (expense), net   [+]-1.4-7.1-9.2-7.6-7.1-48.94.0-3.6
Pre-tax income  -14.4-27.6-6.5-18.3-26.5-83.4-29.2-27.3
Income taxes  0.50.00.00.00.00.00.2-85.3
            Tax rate   0.0%0.0%0.0%0.0%0.0% 312.7%
Earnings from continuing ops  -14.9-27.6-6.5-18.3-26.5-83.4-29.2-27.3
Earnings from discontinued ops         -39.9
Net income  -14.9-27.6-6.5-18.3-26.5-83.4-29.458.0
            Net margin  -31.3%-71.9%-10.4%-33.4%-77.3%-395.9%-128.7%1329.9%
   
Basic EPS   [+]($0.31)($0.62)($0.22)($1.23)($1.80)($6.37)($0.29)($0.29)
Diluted EPS   [+]($0.31)($0.62)($0.22)($1.23)($1.80)($6.37)($0.29)($0.29)
   
Shares outstanding (basic)   [+]48.544.129.114.814.713.1101.494.9
Shares outstanding (diluted)   [+]48.544.129.114.814.713.1101.494.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy